Overall, both NPY and acyl ghrelin levels are increased in patients with obesity and T2D, contributing to adiposity and reduced insulin sensitivity [11,12,38,39], whereas dopamine action is dependent on subtype receptors. The gene discussed is INS; the disease is type 2 diabetes mellitus.